A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
- 17 March 2004
- Vol. 22 (23-24), 3004-3007
- https://doi.org/10.1016/j.vaccine.2004.02.020
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- A Controlled Trial of a Human Papillomavirus Type 16 VaccineNew England Journal of Medicine, 2002
- Neutralization of Human Papillomavirus Type 11 (HPV‐11) by Serum from Women Vaccinated with Yeast‐Derived HPV‐11 L1 Virus‐like Particles: Correlation with Competitive Radioimmunoassay TiterThe Journal of Infectious Diseases, 2001
- A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult VolunteersThe Journal of Infectious Diseases, 2001
- Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle VaccineJNCI Journal of the National Cancer Institute, 2001
- Cervical cancer in Canada: Changing patterns in incidence and mortalityInternational Journal of Gynecologic Cancer, 2001
- Epidemiology of Genital Human Papillomavirus InfectionAmerican Journal Of Medicine, 1997
- Strategies for global control of cervical cancerInternational Journal of Cancer, 1995
- Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in iceland, 1964–1991International Journal of Cancer, 1993